A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
DUBLIN, Ireland, Oct. 26, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces the appointment of Mr. Tom Lindsay to its Board of Directors as an...
DUBLIN, Ireland, June 30, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company's results for the quarter ended March 31, 2022. Quarter...
Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERNDUBLIN, Ireland, June 29, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, May 20, 2022 -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test throughout the...
DUBLIN, Ireland, May 03, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announced strategic investment with...
DUBLIN, Ireland, April 11, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2021 and fiscal year...
DUBLIN, Ireland, April 11, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company ("Trinity Biotech" or the "Company"), today announced a $45 million strategic investment and partnership with MiCo Ltd ("MiCo"). MiCo, a KOSDAQ-listed and...
DUBLIN, Ireland, Feb. 14, 2022 -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO). TrinScreen™ HIV Trinity Biotech's Uni-Gold™ HIV product has been...
DUBLIN, Ireland, Jan. 27, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announced refinancing. Refinancing...
DUBLIN, Ireland, Jan. 25, 2022 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Extraordinary General Meeting (EGM). EGM Results...